Abstract

The transcription factor orthodenticle homeobox 2 (OTX2) has been implicated in the pathogenesis of medulloblastoma, as it is often highly expressed and sometimes amplified in these tumors. Little is known of the downstream pathways regulated by OTX2. We therefore generated MED8A and DAOY medulloblastoma cell lines with doxycycline-inducible OTX2 expression. In both cell lines, OTX2 inhibited proliferation and induced a senescence-like phenotype with senescence-associated β-galactosidase activity. Expression profiles of time series after OTX2 induction in MED8A showed early upregulation of cell cycle genes related to the G(2)-M phase, such as AURKA, CDC25C, and CCNG2. Paradoxically, G(1)-S phase genes such as MYC, CDK4, CDK6, CCND1, and CCND2 were strongly downregulated, in line with the observed G(1) arrest. ChIP-on-chip analyses of OTX2 binding to promoter regions in MED8A and DAOY showed a strong enrichment for binding to the G(2)-M genes, suggesting a direct activation. Their mRNA expression correlated with OTX2 expression in primary tumors, underscoring the in vivo relevance of this regulation. OTX2 induction activated the P53 pathway in MED8A, but not in DAOY, which carries a mutated P53 gene. In DAOY cells, senescence-associated secretory factors, such as interleukin-6 and insulin-like growth factor binding protein 7, were strongly upregulated after OTX2 induction. We hypothesize that the imbalance in cell cycle stimulation by OTX2 leads to cellular senescence either by activating the P53 pathway or through the induction of secretory factors. Our data indicate that OTX2 directly induces a series of cell cycle genes but requires cooperating genes for an oncogenic acceleration of the cell cycle.

Highlights

  • Medulloblastoma is the most common malignant brain tumor in children and accounts for ∼10% of all childhood cancer deaths

  • orthodenticle homeobox 2 (OTX2) expression is specific for medulloblastoma Analysis of mRNA expression data showed that OTX2 is highly expressed in medulloblastoma, but not in other brain or non-brain tumors or normal tissues (Fig. 1A)

  • Expression profiling of medulloblastoma cell lines showed that five cell lines (D283, D341, D425, D458, and D556) highly expressed OTX2, comparable to the levels observed in tumors (Fig. 1A)

Read more

Summary

Introduction

Medulloblastoma is the most common malignant brain tumor in children and accounts for ∼10% of all childhood cancer deaths. Overall survival rates are improving in recent years, current therapies are still associated with serious long-term side effects, including many cognitive defects. A better understanding of the molecular biology of medulloblastomas is needed to find novel treatment modalities and improve overall survival and quality of life. One of the genes implicated in medulloblastoma tumorigenesis is orthodenticle homeobox 2 (OTX2). SAGE analyses initially identified OTX2 as highly expressed in medulloblastoma [1]. OTX2 was found to be strongly amplified in a set of primary tumors and cell lines, suggesting that this gene acts as an oncogene in Authors' Affiliation: Department of Human Genetics, Academic Medical Center, Amsterdam, the Netherlands

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call